Tesla Robotaxi Wait Times Underscore Scaling Hurdles in Texas

What happened

Tesla's April 2026 expansion of unsupervised robotaxis to Dallas and Houston is reportedly plagued by long wait times, per Reuters, signaling that even as the company touts sequential paid-mile growth, operational reality may lag the narrative. The DeepValue master report highlights a mixed Q1'26: automotive gross margin improved to 21.1%, but operating margin remained thin at 4.2%, inventory days-of-supply hit 27, and profit quality relied on one-time warranty and tariff benefits. While autonomy KPIs like 1.28M FSD subscriptions and nearly doubled paid robotaxi miles show progress, the Texas wait times suggest that utilization and customer experience still need to mature before robotaxi becomes a meaningful earnings driver. Regulatory overhang persists—California DMV only lists Tesla for testing with a driver, and NHTSA investigations continue—constraining the bull case of rapid, multi-metro unsupervised expansion. The stock trades at 311x P/E, pricing in perfect autonomy execution; any friction in scaling, such as these wait times, threatens the premium.

Implication

Investors should treat Tesla as a high-variance autonomy play requiring measurable robotaxi utilization growth (paid miles, fleet utilization) to validate the $25B+ capex step-up. The Texas wait times, if persistent, would shift the bull case timeline out, compressing forward multiples. Wait for Q2'26 disclosure confirming sequential paid-mile growth >50% and maintenance of automotive gross margin above ~20% before adding exposure.

Thesis delta

The latest article provides early, real-world evidence that robotaxi scaling is not frictionless, challenging the 'smooth adoption' assumption embedded in the bull case. While the DeepValue report already flagged execution risk (27-day inventory, regulatory scrutiny), the wait times operationalize that risk—meaning the thesis now requires even faster robotaxi improvement to offset potential demand softness in the core auto business.